http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008538711-A

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C2202-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-046
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02C7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-00
filingDate 2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008538711-A
titleOfInvention A therapeutic contact lens for use in pseudo-aphakic eyes and / or eyes undergoing a neurodegenerative process
abstract The present invention is a contact lens for use in pseudo-aphakic eyes and / or eyes that are in the process of macular and retinal degeneration, with a filter having a yellow pigment that protects the eye from short wavelengths (less than 500 nm) in the visible spectrum. The present invention relates to a contact lens obtained by attaching to a contact lens. The present invention eliminates the difficulties and dangers of existing technology for protecting eyes undergoing cataract surgery and improving the protective function of eyes in the course of neurodegeneration, simply by using contact lenses. . The present invention consists of a combination of a standard contact lens, suitable for the human eye, and a yellow dye filter that absorbs short wavelengths of 350-500 nm.
priorityDate 2005-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2724012-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9104717-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01204668-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001517324-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21867852
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136229972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432751576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23611
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16130922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531591
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410504899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426079289
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422600808

Total number of triples: 30.